HIGHLIGHTS
- who: Ana Ion and colleagues from the Department of Dermatology, u2018Elias` Emergency University Hospital, Bucharest, Romania have published the Article: Risks of Biologic Therapy and the Importance of Multidisciplinary Approach for an Accurate Management of Patients with Moderate-Severe Psoriasis and Concomitant Diseases, in the Journal: Biology 2022, 11, 808. of /2022/
- what: The aim of the study was to demonstrate the superiority of secukinumab over placebo at week 12 concerning PASI 75 . Scheme It is believed that infection represents one of the main reasons for discontinuation of Table 2.
- how: Showed that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.